Alleh Lindquist

U.S. regulators are currently making decisions on behalf of the cannabis industry, such as reclassifying it from a Schedule I to a Schedule III controlled substance. The move certainly bodes well for the overall industry, but there's just one problem, according to Christine De La Rosa of The...